Best-possible antiseizure drug therapy after SANAD II
A young woman with focal epilepsy who has failed two first-line antiseizure medications raises important questions about drug selection, tolerability, teratogenicity, and the limits of evidence-based treatment guidelines. This advanced case examines the clinical decision-making process when standard therapies prove insufficient, and explores the broader therapeutic landscape including presurgical evaluation considerations.Topics in this course:
